EICHOR
● Completed
Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer
Condition: Breast Cancer · Sponsor: UNICANCER
About this study
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) and giving them after surgery may kill any tumor cells remaining after surgery. It is not yet known whether docetaxel is more effective than ixabepilone when given after surgery and combination chemotherapy in treating breast cancer. PURPOSE: This randomized phase III trial is studying giving combination chemotherapy followed by docetaxel or ixabepilone to compare how well they work in treating patients who have undergone surgery for nonmetastatic breast cancer.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (86)
| Mayo Clinic Scottsdale | Scottsdale, Arizona, United States | — |
| CCOP - Colorado Cancer Research Program | Denver, Colorado, United States | — |
| Mayo Clinic - Jacksonville | Jacksonville, Florida, United States | — |
| CCOP - Northern Indiana CR Consortium | South Bend, Indiana, United States | — |
| CCOP - Cedar Rapids Oncology Project | Cedar Rapids, Iowa, United States | — |
| Siouxland Hematology-Oncology Associates, LLP | Sioux City, Iowa, United States | — |
| Cancer Center of Kansas, PA - Wichita | Wichita, Kansas, United States | — |
| Duluth Clinic Cancer Center - Duluth | Duluth, Minnesota, United States | — |
| Mayo Clinic Cancer Center | Rochester, Minnesota, United States | — |
| CCOP - Metro-Minnesota | Saint Louis Park, Minnesota, United States | — |
| Southeast Nebraska Hematology Oncology Consultants at Southeast Nebraska Cancer Center | Lincoln, Nebraska, United States | — |
| CCOP - Missouri Valley Cancer Consortium | Omaha, Nebraska, United States | — |
+ 74 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00630032